Meinian Onehealth Healthcare Holdings Co., Ltd. (SHE:002044)
China flag China · Delayed Price · Currency is CNY
6.96
-0.16 (-2.25%)
Feb 13, 2026, 3:04 PM CST

SHE:002044 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
10,44210,65710,8708,6029,2007,824
Other Revenue
45.2245.2223.2114.1815.9624.07
10,48710,70210,8948,6169,2167,848
Revenue Growth (YoY)
-2.45%-1.76%26.44%-6.51%17.43%-7.94%
Cost of Revenue
6,0866,1236,2325,6495,5804,934
Gross Profit
4,4004,5794,6612,9673,6362,914
Selling, General & Admin
3,2803,4303,3952,8632,8192,474
Research & Development
54.3254.9662.6556.3560.2245.91
Other Operating Expenses
34.963.732.61.761.12
Operating Expenses
3,4273,6263,4463,0742,9622,675
Operating Income
973.26952.391,216-106.83674.33239.16
Interest Expense
-313.08-319.37-303.68-291.43-353.66-373.79
Interest & Investment Income
23.9525.1121.6314.0688.041,267
Currency Exchange Gain (Loss)
0.030.03-0.02-0.332.1773.58
Other Non Operating Income (Expenses)
-35.97-20.21-33.94-24.98-32.81-86.88
EBT Excluding Unusual Items
648.19637.95899.55-409.52378.071,119
Impairment of Goodwill
-6.71-6.71-41.86---327.3
Gain (Loss) on Sale of Investments
10.99-29.371.785.84-0.57-4.43
Gain (Loss) on Sale of Assets
-10.23-8.49-6.89-8.16-6.17-4.92
Asset Writedown
-17.68-18.24-26.96-66.84-28.27-36.77
Legal Settlements
-----7.92-5.6
Other Unusual Items
17.3717.3722.4327.9629.6136.51
Pretax Income
641.94592.52848.06-450.72364.75776.32
Income Tax Expense
222.03183.53179.2350.86205.57140.56
Earnings From Continuing Operations
419.91408.99668.82-501.58159.19635.76
Minority Interest in Earnings
-110.44-126.75-163.2-57.44-97.61-84.74
Net Income
309.47282.24505.62-559.0261.58551.02
Net Income to Common
309.47282.24505.62-559.0261.58551.02
Net Income Growth
0.76%-44.18%---88.83%-
Shares Outstanding (Basic)
6,0744,0323,8893,9933,0793,936
Shares Outstanding (Diluted)
6,0744,0323,8893,9933,0793,936
Shares Change (YoY)
106.06%3.67%-2.60%29.69%-21.77%4.48%
EPS (Basic)
0.050.070.13-0.140.020.14
EPS (Diluted)
0.050.070.13-0.140.020.14
EPS Growth
-51.10%-46.15%---85.71%-
Free Cash Flow
1,3581,2161,6161,1281,624656.36
Free Cash Flow Per Share
0.220.300.410.280.530.17
Dividend Per Share
0.0130.0130.019---
Dividend Growth
-28.95%-28.95%----
Gross Margin
41.96%42.78%42.79%34.44%39.46%37.13%
Operating Margin
9.28%8.90%11.16%-1.24%7.32%3.05%
Profit Margin
2.95%2.64%4.64%-6.49%0.67%7.02%
Free Cash Flow Margin
12.95%11.36%14.83%13.09%17.62%8.36%
EBITDA
1,4031,3931,672337.891,094646.8
EBITDA Margin
13.38%13.02%15.35%3.92%11.87%8.24%
D&A For EBITDA
429.52440.95456.19444.73419.94407.64
EBIT
973.26952.391,216-106.83674.33239.16
EBIT Margin
9.28%8.90%11.16%-1.24%7.32%3.05%
Effective Tax Rate
34.59%30.97%21.13%-56.36%18.11%
Revenue as Reported
10,48710,70210,8948,6169,2167,848
Advertising Expenses
-100.4972.5367.8194.9694.03
Source: S&P Global Market Intelligence. Standard template. Financial Sources.